Latest News and Press Releases
Want to stay updated on the latest news?
-
deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnostic system for direct-from-blood rapid pathogen detection Round co-led by Columbus Venture Partners, Panakès...
-
deepull receives FDA Breakthrough Device Designation for its UllCORE Bloodstream Infection Test Barcelona, Spain – 2 December 2024 – deepull, a medical diagnostics company developing culture-free...
-
deepull appoints Didier Deltort to its Board of Directors Barcelona, Spain – 22 May 2024 – deepull, a medical diagnostics company developing culture-free diagnostic solutions for rapid pathogen...
-
deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ESCMID 2024 UllCORE is designed to transform life-saving clinical decision making for sepsis...
-
deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing and Sales Officer Kimberle Chapin brings significant expertise in microbiology and infectious...
-
PRESS RELEASE Luxembourg, 13th December 2022 Spain: EUR 20 million EIB loan to DeepUll accelerates early detection and diagnosis of Sepsis The EIB and...
-
DeepUll raises €13M Series B financing to progress early sepsis recognition platformFinancing led by new investors Innvierte and an undisclosed strategic investor with participation from existing...
-
DeepUll Appoints Richard Ivey to its Board of Directors Diagnostics industry veteran with forty years’ experience to support DeepUll in its continued development of its early sepsis identification...
-
DeepUll Appoints Richard Ivey to its Board of Directors Diagnostics industry veteran with forty years’ experience to support DeepUll in its continued development of its early sepsis identification...